Authors


Kenneth Hung, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Andres Avellaneda Ojeda, MD

Latest:

Cannabis, Psychosis, and the Legal Implications: Chicken or Egg?

Explore the relationship between cannabis use and psychosis.


Cassandra Ann Gibson, MD, MS

Latest:

Bringing the Hospital Home: Meeting Teens in Crisis Where They Are

Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.


Robert Steel, PhD

Latest:

Vaccine Mandate Exemptions for Anxiety: Ethical and Practical Considerations

Does anxiety justify an exemption from vaccine mandates among health care workers?


Damir Huremović, MD, MPP

Latest:

A New CME: Continuing Moral Education

Every phase of the COVID-19 pandemic brings new ethical challenges.


Patricia Gherovici, PhD

Latest:

Latinx Psychoanalysis

A psychoanalyst shares her experience working with patients whose lives are marked by poverty, migration, and race and gender discrimination.


Amitai Ziv, MD

Latest:

Mental Health Responses to the Recent Conflict in Israel

What is the psychiatric impact of the current war in Gaza?


Jake Goodman, MD, MBA

Latest:

I Revealed That I Take Medication for My Mental Health to Millions Online. Here’s What Happened.

"When I was very young and dreaming of becoming a doctor, I never witnessed a physician open up about their mental health, let alone admit to taking medication for it..."


Bryson C. Lochte, MD

Latest:

Current Treatments for Cannabis Use Disorder

While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.


Kristel Carrington, MD

Latest:

Navigating New Terrain: Clinician Education at the Crossroads of Psychedelics and Medical Ethics

Psychedelics: it is time to integrate this treatment option into clinical care while holding fast to the principles of medical ethics.


Danny Freed

Latest:

Blueprint

The CEO and founder of Blueprint talks how they are improving the quality of mental health care by putting the proper data infrastructure in place.


Michael D. Banov, MD

Latest:

The Online, At-Home Ketamine Experience: A Clinician’s Dilemma

At-home ketamine treatment initiated by an online provider presents many legal, clinical, and ethical challenges...


Charles F. Reynolds III, MD

Latest:

Prolonged Grief Disorder: The Derailed Grief Process

Prolonged grief disorder honors patients' loss by helping them integrate that loss into their lives—transforming and restoring lives of purpose and meaning.


Neda F. Gould, PhD

Latest:

Reducing Stress Through Mindfulness

Listen to the sounds of nature and release the tension you are holding.


Burhan Khan, MBBS

Latest:

The Overdose Conundrum

A patient loss does not undo or discard the multitude of meaningful life changing and life preserving work done.


Rikera Curry, MD

Latest:

Mental Health Equity Begins With Resident Recruitment: The Impact of Recruiting a Diverse Psychiatric Workforce

Mental health equity is not possible without a diverse workforce. Recruiting diverse psychiatrists is the first step.


Nicole Hockley

Latest:

The Mental Health Crisis Facing Our Youth

Nicole Hockley, co-founder and managing director of Sandy Hook Promise, talks about the mental health strain COVID-19 has placed on youth.


Sarah E. Levitt, MSc, MD, FRCPC

Latest:

Palliative Psychiatry and Assisted Suicide for Mental Illness: Not 1 and the Same

Does palliative psychiatry inevitably lead to advocacy for assisted suicide?


Amy Harrington, MD

Latest:

Methamphetamine-Associated Psychosis: What Should Clinicians Know?

Exploring the association between methamphetamine use and the development of psychotic symptoms, such as paranoid delusions, ideas of reference, and auditory hallucinations.


Damian B. Kim, MD, LFAPA, FAAPDPP

Latest:

Is Psychiatry Becoming Extinct?

A look at the different types of mental health disorders and the role of psychodynamic psychotherapy.



Harsha Rajasimha, MS, PhD

Latest:

The Future of Clinical Trials: Diversity, Transparency, and Reform

How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?


Myles Solan

Latest:

Mental Health Disparities Among Black Americans During the COVID-19 Pandemic

The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.


Rodney Luster, PhD, LPC

Latest:

First Responders and Mental Health: When Heroes Need Rescuing

As Suicide Prevention Month continues, we take a look at the mental health of a group constantly caring for others: first responders.


Romina Mizrahi, MD, PhD

Latest:

Synaptic Dysfunction in Psychosis Explored at ACNP Meeting

New research links reduced synaptic density,early psychosis, and cannabis use, offering insights into negative symptoms and potential interventions.


William C. Becker, MD

Latest:

You Say Pain. I Say Addiction. Let’s Call the Whole Thing Off

This CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.


Ulrike Schmidt, PhD, MRCPsych

Latest:

The Status of Neuromodulation Trials in Eating Disorders

"20% to 30% of patients develop a persistent, hard-to-treat illness."


Leah C. Susser, MD

Latest:

Understanding Premenstrual Exacerbations of Psychiatric Illnesses

PME affects many women, yet it remains under-recognized in clinical practice and in research.


Robert C. Larsen, MD, MPH

Latest:

Legislating Medical Procedures

The protections of Roe v. Wade may be coming to an end. What will this mean for mental health?


Olivia M. Dean, PhD

Latest:

Exploring N-Acetylcysteine in Psychiatry

A synthetic derivate of the endogenous amino acid L-cysteine and a precursor of glutathion, N-Acetylcysteine shows promise for treating a variety of psychiatric disorders.

© 2025 MJH Life Sciences

All rights reserved.